EQS-News: TVM Capital Life Science announces up to USD 24 million investment in oncology company, Recurv Pharma, Inc.
EQS-News: TVM Life Science Management GmbH / Key word(s): Investment TVM Capital Life Science announces up to USD 24 million investment in oncology company, Recurv Pharma, Inc. 01.02.2023 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. TVM Capital Life Sci...
Source: boersennews.de